Wendy's short interest has climbed to one of its highest readings on record, and a sudden 4% snapback after a brutal single-session collapse is raising an uncomfortable question for anyone still holding a short…
Rivian's CFO is walking out the door just as the company's most important vehicle ramp gets underway, and shareholders are voting hard on what that timing means for the equity story.
One Saturday at an auction block cleared a barn that took four decades to fill, but the financial ripple from that single afternoon kept arriving long after the tractors were gone.
Spotify just posted its strongest fundamental quarter ever while its stock sits well below last year's peak, and that disconnect points to something worth paying close attention to before 2030.
Her annuity check arrived every month like clockwork, so she assumed the IRS was satisfied. It turned out the tax code had a completely separate opinion about the rest of her IRA, and the…
A value investor ran Palantir through the same stress test he uses on every high-growth stock, and the result left him with a very specific price and a frank admission about what he still…
Bitcoin is holding steady near a key level while the miners that produce it are cratering, and that split tells investors something important about where the smart money is actually flowing this cycle.
Ulta Beauty posted a clean earnings beat and raised its full year outlook, yet traders punished the stock in heavy Friday volume. Understanding why requires a closer look at the pattern that has haunted…
Azure just crossed $100 billion and commercial bookings are stacking up at a pace that redefines what valuation ceiling even means for a company this size. The math toward an unprecedented market cap milestone…
Retiring to Sun City on Social Security alone sounds straightforward until two budget lines most people skip quietly blow up the math before age 65 even arrives.
BioNTech's colorectal cancer vaccine just collapsed in a Phase 2 trial, dragging Moderna down with it despite last week's melanoma triumph, and the fallout is forcing investors to rethink how far mRNA technology can…
Schwab just handed 39.9 million account holders a path to trading Solana, Avalanche, and Chainlink, but a listing and a demand event are very different things, and the real price mover that day had…
Marvell has surged over 180% this year on AI infrastructure demand, but cooling momentum and a stretched valuation now put buyers in a difficult spot. The case for owning MRVL is strong, yet when…
Amazon is pouring hundreds of billions into AI infrastructure while free cash flow turns negative, yet something unexpected is showing up in its retail data that suggests this spending may be doing far more…
Bears spent months building a case that AI would hollow out Salesforce and eventually topple Nvidia, and then a single earnings night arrived and put both arguments on trial at once.
